Biblio

Journal Article
Wong N-HMickey, So CWai Eric. Novel therapeutic strategies for MLL-rearranged leukemias. Biochim Biophys Acta Gene Regul Mech. 2020:194584.
Zuo M, Rashid A, Churi C, Vauthey J-N, Chang P, Li Y, Hung M-C, Li D, Javle M. Novel therapeutic strategy targeting the Hedgehog signalling and mTOR pathways in biliary tract cancer. Br J Cancer. 2015.
Shaikh U, Khan A, Kumari P, Ishfaq A, Ekhator C, Yousuf P, Nagaraj RHalappa, Raza H, Rehman UUr, Zaman MUzair, et al. Novel Therapeutic Targets for Fibrodysplasia Ossificans Progressiva: Emerging Strategies and Future Directions. Cureus. 2023;15(7):e42614.
Zhu Y, Bao M, Wang T, Ai X, Qiu D, Wang C. Novel therapeutic targets, including IGFBP3, of umbilical cord mesenchymal stem cell-conditioned medium in intrauterine adhesion. Biol Open. 2024.
Sher EKarahmet, Džidić-Krivić A, Karahmet A, Beća-Zećo M, Farhat EKarahmet, Softić A, Sher F. Novel therapeutical approaches based on neurobiological and genetic strategies for diabetic polyneuropathy - A review. Diabetes Metab Syndr. 2023;17(11):102901.
Scarfò L. Novel therapies and combinations in CLL refractory to BTK inhibitors and venetoclax. Hematology Am Soc Hematol Educ Program. 2022;2022(1):316-322.
Gaudet D. Novel therapies for severe dyslipidemia originating from human genetics. Curr Opin Lipidol. 2016.
Vengoji R, Ponnusamy MP, Rachagani S, Mahapatra S, Batra SK, Shonka N, Macha MA. Novel Therapies Hijack the Blood Brain Barrier to Eradicate Glioblastoma Cancer Stem Cells. Carcinogenesis. 2018.
Abaza Y, Patel AAshwin. Novel Therapies in Myelodysplastic Syndrome: Where Do Venetoclax and Isocitrate Dehydrogenase Inhibitors Fit in?. Cancer J. 2023;29(3):188-194.
Zhang Y, Wu S. Novel therapy for advanced gastric cancer. World J Gastrointest Oncol. 2015;7(11):263-270.
Hasan AHameed, Murugesan S, Amran SItri, Chander S, Alanazi MM, Ben Hadda T, Shakya S, Pratama MRizki Fadh, Das B, Biswas S, et al. Novel thiophene Chalcones-Coumarin as acetylcholinesterase inhibitors: Design, synthesis, biological evaluation, molecular docking, ADMET prediction and molecular dynamics simulation. Bioorg Chem. 2021;119:105572.
Tan X, Wen Q, Chen G, Wan K, Liu X, Ma Y-Y, Wang M-H, Zhang X, Zhang C. Novel third-generation tyrosine kinase inhibitor for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a case study. Anticancer Drugs. 2022.
Zheng X, Liu Y, Liu Y, Pan Y, Yao Q. Novel three-dimensional bioglass functionalized gelatin nanofibrous scaffolds for bone regeneration. J Biomed Mater Res B Appl Biomater. 2020.
Khabazi A, Maralani M, Andalib S, Sakhinia E. A novel TNFRSF1A gene mutation in a patient with tumor necrosis factor receptor-associated periodic syndrome. Hematol Oncol Stem Cell Ther. 2016.
Ibuki M, Horiguchi I, Sakai Y. A novel tool for suspension culture of human induced pluripotent stem cells: Lysophospholipids as a cell aggregation regulator. Regen Ther. 2019;12:74-82.
Hao J, Huang J, Hua C, Zuo Y, Yu W, Wu X, Li L, Xue G, Wan X, Ru L, et al. A novel TOX3-WDR5-ABCG2 signaling axis regulates the progression of colorectal cancer by accelerating stem-like traits and chemoresistance. PLoS Biol. 2023;21(9):e3002256.
Okuda H, Kiuchi H, Takao T, Miyagawa Y, Tsujimura A, Nonomura N, Miyata H, Okabe M, Ikawa M, Kawakami Y, et al. A Novel Transcriptional Factor Nkapl Is a Germ Cell-Specific Suppressor of Notch Signaling and Is Indispensable for Spermatogenesis. PLoS One. 2015;10(4):e0124293.
Khandaker I, Funderburgh JL, Geary ML, Funderburgh ML, Jhanji V, Du Y, Yam GHin-Fai. A novel transgenic mouse model for corneal scar visualization. Exp Eye Res. 2020:108270.
Liu Y, Wang J, Liu S, Kuang M, Jing Y, Zhao Y, Wang Z, Li G. A novel transgenic murine model with persistently brittle bones simulating osteogenesis imperfecta type I. Bone. 2019.
Rastogi A, Jude EB. Novel treatment modalities for painful diabetic neuropathy. Diabetes Metab Syndr. 2021;15(1):287-293.
Barker A, Hurley J. Novel treatment options for fecal incontinence. Clin Colon Rectal Surg. 2014;27(3):116-20.
Tallis E, Borthakur G. Novel treatments for relapsed/refractory acute myeloid leukemia with mutations. Expert Rev Hematol. 2019.
Kucharzewski M, Rojczyk E, Wilemska-Kucharzewska K, Wilk R, Hudecki J, Los MJ. Novel trends in application of stem cells in skin wound healing. Eur J Pharmacol. 2018.
Rajabpour FVand, Raoofian R, Habibi L, Akrami SMohammad, Tabrizi M. Novel Trends in Genetics: Transposable Elements and Their Application in Medicine. Arch Iran Med. 2014;17(10):702-712.
Darrow EM, Chadwick BP. A novel tRNA variable number tandem repeat at human chromosome 1q23.3 is implicated as a boundary element based on conservation of a CTCF motif in mouse. Nucleic Acids Res. 2014.

Pages